Stockreport

AVEO and Biodesix Announce Positive Results from Phase Ib Ficlatuzumab-Cytarabine Trial in Patients with Relapsed and Refractory AML

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com
PDF - Data presented during poster session at the AACR 2019 Annual Meeting - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- AVEO Oncology (NASDAQ:AVEO) and B [Read more]